Apotex urges Third Circuit to hold Mylan, Ranbaxy fully responsible for competitive harm in Provigil pay-for-delay case
MLex Summary: Apotex filed a brief urging the US Court of Appeals for the Third Circuit to hold Mylan Laboratories and Ranbaxy Pharmaceuticals jointly and severally liable for illegally delaying generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article